Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Abnormal Ventilatory Response to Carbon Dioxide: a Potential Biomarker for Seizure Induced Respiratory Depression & Modification by SSRI

NCT02929667 is registered in ClinicalTrials.gov with Rup Kamal Sainju as lead sponsor.

NCT NCT02929667
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02929667 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Abnormal Ventilatory Response to Carbon Dioxide: a Potential Biomarker for Seizure Induced Respiratory Depression & Modification by SSRI
Lead sponsor
Rup Kamal Sainju
Phase
Phase 2
Overall status
Completed
Start date
February 16, 2017
Completion date
March 6, 2019
Enrollment
30 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

epilepsy, sudep